Status
Conditions
Treatments
About
This is a multicenter randomized controlled study. By comparing patients with sinus bradycardia undergoing cardiac autonomic ganglion ablation and pacemaker therapy, and long-term follow-up to evaluate its safety and effectiveness after surgery, in order to evaluate the safety and effectiveness of cardiac autonomic ganglion ablation in the treatment of sinus bradycardia.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Structural heart disease, heart surgery history;
Drug-induced SB, sinus pause >2.0 s, positive atropine test, corrected sinus node recovery time (cSNRT) >525 ms;
Any atrial or ventricular arrhythmia, or a history of ablation procedures to treat atrial tachyarrhythmias;
With Significant congenital heart disease, ejection fraction was <40% measured by echocardiography;
Allergic to contrast media;
Contraindication to anticoagulation medications;
Severe pulmonary disease e.g. restrictive pulmonary disease, chronic obstructive disease (COPD);
Poor general health; 10.Life expectancy less than 6 months.
Primary purpose
Allocation
Interventional model
Masking
240 participants in 2 patient groups
Loading...
Central trial contact
Xu Liu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal